Uemura Tomonari, Usui Akihiko, Tokuda Yoshiyuki, Narita Yuji, Mutsuga Masato
Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 466-8560, Japan.
Department of Cardiovascular Surgery, Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan.
Gen Thorac Cardiovasc Surg. 2025 Jun 12. doi: 10.1007/s11748-025-02167-6.
Systolic anterior motion (SAM) is an important factor for hypertrophic obstructive cardiomyopathy (HOCM) patients with a hypertrophic interventricular septum. We developed the 'floating stitch technique' to relieve SAM and have used it since 2017. The mid-term results of the floating stitch technique are reported.
Ten consecutive HOCM patients (5 male, mean age 65.6 years) who underwent septal myectomy and the floating stitch technique from 2017 to 2022 were included. All patients underwent preoperative, pre-discharge, and annual follow-up echocardiographic evaluations. The median postoperative observation period was 3.5 (range 1.2-6.6) years.
There were no cases of cutting or elongation of the floating stitch during the follow-up period. The median mitral valve area (MVA) was 2.9 [interquartile range (IQR) 2.6-3.1] cm before surgery, 2.6 (IQR 2.2-2.7) cm before discharge, and 2.6 (IQR 2.2-2.8) cm at the latest follow-up. There were no cases of mitral stenosis clinically. All cases showed a significant decrease in the left ventricular outflow tract pressure gradient after surgery, but one case required re-operation due to recurrent obstruction at the mid-cardiac position. SAM did not recur in any cases, and all patients were in NYHA class 1 at the latest follow-up.
The floating stitch technique showed an excellent SAM-suppression effect and durability. MVA decreased about 10% following the floating stitch technique, but sufficient area was secured without functional mitral stenosis. The combination of septal myectomy and floating stitch technique is a simple and reproducible procedure for HOCM, especially with severe SAM.
收缩期前向运动(SAM)是肥厚性梗阻性心肌病(HOCM)合并肥厚室间隔患者的一个重要因素。我们开发了“漂浮缝合技术”来缓解SAM,并自2017年起开始使用。本文报告了漂浮缝合技术的中期结果。
纳入2017年至2022年期间连续10例接受室间隔心肌切除术和漂浮缝合技术的HOCM患者(5例男性,平均年龄65.6岁)。所有患者均接受术前、出院前和每年的随访超声心动图评估。术后中位观察期为3.5年(范围1.2 - 6.6年)。
随访期间无漂浮缝线切割或延长的病例。术前二尖瓣面积(MVA)中位数为2.9[四分位间距(IQR)2.6 - 3.1]cm²,出院前为2.6(IQR 2.2 - 2.7)cm²,最近一次随访时为2.6(IQR 2.2 - 2.8)cm²。临床上无二尖瓣狭窄病例。所有病例术后左心室流出道压力梯度均显著降低,但有1例因心脏中部复发性梗阻需要再次手术。所有病例均未出现SAM复发,最近一次随访时所有患者均处于纽约心脏协会(NYHA)心功能Ⅰ级。
漂浮缝合技术显示出优异的SAM抑制效果和耐久性。漂浮缝合技术后MVA下降约10%,但仍保留了足够的面积,未出现功能性二尖瓣狭窄。室间隔心肌切除术和漂浮缝合技术相结合是一种针对HOCM,尤其是伴有严重SAM的简单且可重复的手术方法。